Kelly Thomas Patrick
Chief Financial Officer at Deciphera Pharmaceuticals, Inc.
- Sold, on record
- $6.5M
- Dollars the filings state
- Form 4 sales
- 24
- Latest Feb 16, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Deciphera Pharmaceuticals, Inc.Chief Financial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Deciphera Pharmaceuticals, Inc.Plan not statedJun 16, 2022 2022
Sold 1,768 shares at $10.75 ($19k)
Kelly Thomas Patrick, Chief Financial Officer
Sold 3.7% of holdings ($514k position)46,080 shares left0.8x usual sizeFiling
- 2 Form 4 sale Deciphera Pharmaceuticals, Inc.Plan not statedJan 17, 2023 +215 days
Sold 2,403 shares at $21.24 ($51k)
Kelly Thomas Patrick, Chief Financial Officer
Sold 5.2% of holdings ($979k position)43,677 shares left1.8x usual sizeFiling
- 3 Form 4 sale Deciphera Pharmaceuticals, Inc.Plan not statedFeb 16, 2023 +30 days
Sold 1,370 shares at $15.10 ($21k)
Kelly Thomas Patrick, Chief Financial Officer
Sold 2.3% of holdings ($908k position)58,795 shares left0.9x usual sizeFiling
- 4 Form 4 sale Deciphera Pharmaceuticals, Inc.No planJun 16, 2023 +120 days
Sold 1,655 shares at $14.40 ($24k)
Kelly Thomas Patrick, Chief Financial Officer
No 10b5-1 planSold 2.8% of holdings ($847k position)57,140 shares left1.1x usual sizeFiling
- 5 Form 4 sale Deciphera Pharmaceuticals, Inc.No planOct 30, 2023 +136 days
Sold 2,316 shares at $12.02 ($28k)
Kelly Thomas Patrick, Chief Financial Officer
No 10b5-1 planSold 3.5% of holdings ($786k position)63,068 shares left1.4x usual sizeFiling
- 6 Form 4 sale Deciphera Pharmaceuticals, Inc.No planDec 13, 2023 +44 days
Sold 2,792 shares at $15.37 ($43k)
Kelly Thomas Patrick, Chief Financial Officer
No 10b5-1 planSold 3.9% of holdings ($1.1M position)68,520 shares left1.6x usual sizeFiling
- 7 Form 4 sale Deciphera Pharmaceuticals, Inc.No planJan 16, 2024 +34 days
Sold 2,435 shares at $14.47 ($35k)
Kelly Thomas Patrick, Chief Financial Officer
No 10b5-1 planSold 3.6% of holdings ($991k position)66,085 shares left1.4x usual sizeFiling
- 8 Form 4 sale Deciphera Pharmaceuticals, Inc.No planFeb 16, 2024 +31 days
Sold 3,010 shares at $15.62 ($47k)
Kelly Thomas Patrick, Chief Financial Officer
No 10b5-1 planSold 3.6% of holdings ($1.3M position)80,350 shares left1.5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (24)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 16, 2024 | Feb 20, 2024 | Deciphera Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 3,010 | $47k | 3.6% | No plan | SEC |
| Jan 16, 2024 | Jan 18, 2024 | Deciphera Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 2,435 | $35k | 3.6% | No plan | SEC |
| Dec 13, 2023 | Dec 14, 2023 | Deciphera Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 2,792 | $43k | 3.9% | No plan | SEC |
| Oct 30, 2023 | Oct 31, 2023 | Deciphera Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 2,316 | $28k | 3.5% | No plan | SEC |
| Jun 16, 2023 | Jun 21, 2023 | Deciphera Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 1,655 | $24k | 2.8% | No plan | SEC |
| Feb 16, 2023 | Feb 17, 2023 | Deciphera Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 1,370 | $21k | 2.3% | Plan not stated | SEC |
| Jan 17, 2023 | Jan 19, 2023 | Deciphera Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 2,403 | $51k | 5.2% | Plan not stated | SEC |
| Jun 16, 2022 | Jun 21, 2022 | Deciphera Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 1,768 | $19k | 3.7% | Plan not stated | SEC |
| Feb 16, 2022 | Feb 18, 2022 | Deciphera Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 1,368 | $12k | 2.8% | Plan not stated | SEC |
| Feb 16, 2021 | Feb 18, 2021 | Deciphera Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 524 | $26k | 7.4% | Plan not stated | SEC |
| Sep 14, 2020 | Sep 16, 2020 | Deciphera Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 3,000 | $150k | 29.9% | Unusual | SEC |
| Sep 10, 2020 | Sep 10, 2020 | Deciphera Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 9,000 | $416k | 56.1% | Unusual | SEC |
| May 11, 2020 | May 13, 2020 | Deciphera Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 12,000 | $662k | 63.0% | Unusual | SEC |
| Jan 3, 2020 | Jan 6, 2020 | Deciphera Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 12,000 | $692k | 100.0% | Unusual | SEC |
| Dec 23, 2019 | Dec 26, 2019 | Deciphera Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 40,000 | $2.7M | 100.0% | Unusual | SEC |
| Oct 28, 2019 | Oct 30, 2019 | Deciphera Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 3,750 | $150k | 100.0% | Unusual | SEC |
| Sep 11, 2019 | Sep 13, 2019 | Deciphera Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 11,250 | $393k | 100.0% | Unusual | SEC |
| Aug 13, 2019 | Aug 13, 2019 | Deciphera Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 11,250 | $464k | 100.0% | Unusual | SEC |
| Jun 19, 2019 | Jun 21, 2019 | Deciphera Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 177 | $4k | 100.0% | Unusual | SEC |
| Jun 3, 2019 | Jun 5, 2019 | Deciphera Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 2,100 | $53k | 100.0% | Unusual | SEC |
| May 22, 2019 | May 23, 2019 | Deciphera Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 1,473 | $37k | 100.0% | Unusual | SEC |
| May 1, 2019 | May 3, 2019 | Deciphera Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 13,500 | $310k | 100.0% | Unusual | SEC |
| Feb 19, 2019 | Feb 20, 2019 | Deciphera Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 1,500 | $45k | 100.0% | Unusual | SEC |
| Jan 7, 2019 | Jan 9, 2019 | Deciphera Pharmaceuticals, Inc. | Chief Financial Officer | Form 4 sale | 5,000 | $126k | 100.0% | Unusual | SEC |